Novel pebtide and gene vaccination approaches to modulate lupus nephritis.

被引:0
|
作者
Singh, RR [1 ]
Yang, JQ [1 ]
Fan, GC [1 ]
机构
[1] Univ Cincinnati, Cincinnati, OH 45221 USA
关键词
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:369A / 370A
页数:2
相关论文
共 50 条
  • [31] Kidney Transplant Outcome in the Patients with Lupus Nephritis.
    Kim, Y.
    Lee, H.
    Chin, H.
    Kim, Y.
    Han, S.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 : 692 - 692
  • [32] The influence of prolactin on the inflammatory component of lupus nephritis.
    Dugan, Amy
    Morel, Laurence
    JOURNAL OF IMMUNOLOGY, 2010, 184
  • [33] RITUXIMAB IN LUPUS NEPHRITIS. REAL CLINICAL PRACTICE
    Ramos Giraldez, C.
    Velloso Feijoo, M. L.
    Rodriguez Montero, S.
    Marenco, J. L.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1489 - 1489
  • [34] The value of a partial remission in severe lupus nephritis.
    Katz, Robert S.
    Korbet, Stephen M.
    Schwartz, Melvin M.
    Lewis, Edmund J.
    ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S824 - S824
  • [35] The role of aldosterone blockade in murine lupus nephritis.
    Monrad, Seetha
    Killen, Paul D.
    Bradke, Amanda
    Mehta, Hemal
    Kaplan, Mariana J.
    ARTHRITIS AND RHEUMATISM, 2006, 54 (12): : 4090 - 4090
  • [36] Successful use of mycophenolate mofetil for lupus nephritis.
    Stephany, BR
    Holzman, LB
    McCune, WJ
    Somers, EC
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 : 670A - 670A
  • [37] The efficacy and safety of cyclosporin A in refractory lupus nephritis.
    Ikeuchi, Hidekazu
    Kuroiwa, Takashi
    Sakurai, Noriyuki
    Kaneko, Yoriaki
    Hiromura, Keiju
    Nojima, Yoshihisa
    ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S436 - S437
  • [38] The prevalences and clinical characteristics of ANCAs in lupus nephritis.
    Chin, HJ
    Ahn, C
    Lim, CS
    Park, IS
    Han, JS
    Kim, S
    Lee, JS
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1997, 8 : A0400 - A0400
  • [39] The antiphospholipid-related component of lupus nephritis.
    Daugas, E
    Huong, DLT
    Nochy, D
    Beaufils, H
    Piette, JC
    Hill, G
    ARTHRITIS AND RHEUMATISM, 1999, 42 (09): : S365 - S365
  • [40] 2'chloroxyadenosine (Cda) treatment in lupus nephritis.
    Davis, JC
    Klippel, J
    Boumpas, D
    Yarboro, C
    Larsen, A
    Scott, D
    ARTHRITIS AND RHEUMATISM, 1996, 39 (09): : 1358 - 1358